πStep 1. Curriculum Coverage
This topic introduces the biological and public-health foundation of coronary artery disease. It links lipid metabolism, atherosclerotic plaque formation, CVD risk factors, population epidemiology, prevention, and lipid-lowering pharmacology.
π¬ Pathology
Β
β’ Discuss the risk factors, morphology, pathological changes and consequences of atherosclerotic plaque
π Pharmacology
Β
- Briefly describe the types of dyslipidemias
β’ List the lipid-lowering drug classes
β’ Explain the mechanism of action, effect on serum lipid profile and adverse effects of each of the five lipid-lowering drug classes
β’ Discuss drug-drug interactions of lipid-lowering drug
Β
π Community Medicine
Β
- Define cardiovascular disease
β’ Elaborate the concept of CVD risk stratification
β’ Describe the epidemiology of cardiovascular diseases and explain cardiovascular diseases of public-health importance globally and in Pakistan
β’ Explain the known risk factors of CVD and cultural, racial and gender differences in CVD prevalence and incidence
β’ Describe the epidemiology of hypertension and its public-health importance globally and in Pakistan
π Basic Science Spiral Link
πΉ Biochemistry
β’ Classify and describe the types of lipoproteins
β’ Summarize cholesterol synthesis
π©Ί Clinical Integration
Β
β’ Discuss CAD risk factors and strategies to reduce them
β’ Discuss strategies for primary and secondary prevention of coronary heart disease in the outpatient setting
